We are live on ! Find out more
CAH icon

Cardinal Health

929 hedge funds and large institutions have $17.1B invested in Cardinal Health in 2022 Q4 according to their latest regulatory filings, with 163 funds opening new positions, 290 increasing their positions, 344 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more first-time investments, than exits

New positions opened: 163 | Existing positions closed: 65

25% more call options, than puts

Call options by funds: $228M | Put options by funds: $182M

12% more funds holding in top 10

Funds holding in top 10: 1719 (+2)

10% more funds holding

Funds holding: 848929 (+81)

9% more capital invested

Capital invested by funds: $15.7B → $17.1B (+$1.36B)

1.57% less ownership

Funds ownership: 86.5%84.93% (-1.6%)

16% less repeat investments, than reductions

Existing positions increased: 290 | Existing positions reduced: 344

Holders
929
Holders Change
+81
Holders Change %
+9.55%
% of All Funds
14.89%
Holding in Top 10
19
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+11.76%
% of All Funds
0.3%
New
163
Increased
290
Reduced
344
Closed
65
Calls
$228M
Puts
$182M
Net Calls
+$46M
Net Calls Change
-$70.7M

CAH Hedge Fund Activity: Q4 2022 in Review

929 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q4 2022, worth a combined $17.1B — up 8.7% from $15.7B a quarter earlier.

Buyers outnumbered sellers: 163 funds opened new CAH positions and 65 closed out — a net gain of 98 holders — while 290 added to existing stakes and 344 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $101M. The largest seller was T. Rowe Price Associates, cutting an estimated $244M.

  • 929 institutional investors held Cardinal Health (CAH) as of Q4 2022, up from 848 in Q3 2022.
  • Funds reported $17.1B of Cardinal Health stock for Q4 2022, up 8.7% quarter-over-quarter.
  • 163 funds opened new Cardinal Health positions in Q4 2022 and 65 closed out, a net change of +98 holders.
  • The largest Cardinal Health buyer in Q4 2022 was Arrowstreet Capital, an estimated $101M added.
  • The largest Cardinal Health seller in Q4 2022 was T. Rowe Price Associates, an estimated $244M sold.

Based on aggregated 13F filings for Q4 2022.